Intelligent Bio Solutions Reports Fiscal 2025 Fourth Quarter and Full Year Results, Highlighting Progress on Planned U.S. Market Expansion, Revenue Growth and Increased Operational Efficiencies

Company advanced efforts to secure U.S. FDA 510(k) clearance to advance on path towards planned U.S. market expansion beyond Forensic Use Only settings Fourth quarter sequential and year-on-year revenue growth of 16%, supported by increased demand for drug testing...

NextNRG Reports Q2 2025 Revenues Up 166% Year-Over-Year

Record-Breaking Growth Highlights Execution of Integrated Energy Infrastructure Strategy Strong Operational Metrics Drive 189% Gross Profit Growth as Multi-Revenue Platform Scales MIAMI, Aug. 15, 2025 (GLOBE NEWSWIRE) — NextNRG, Inc. (NASDAQ:NXXT), a pioneer in...

Jones Soda Reports Second Quarter 2025 Results

SEATTLE, Aug. 15, 2025 /PRNewswire/ – Jones Soda Co. (CSE:JSDA) (OTCQB:JSDA) (“Jones Soda” or the “Company”), today announced its financial results for the second quarter ended June 30, 2025. Second Quarter 2025 Financial Summary vs....